Dr. Mathias Flume - AMNOG will change in 2022, but how?
From MAP - Market Access Podcast · 34:16
Show by Dr. Stefan Walzer
In this Podcast episode, Dr. Stefan Walzer is talking with Dr. Mathias Flume about the AMNOG process as well as interesting details about the market access process in Germany.Mathias is a core stakeholder within the regional payer system in Germany at one of the most innovative Statutory Health Insurance Physician Associations (KV Westphalia-Lippe). Mathias brings the payer view into the discussion of 10 years AMNOG. Success or failure?
More episodes of MAP - Market Access Podcast
More episodes
- How Will the EU JCA Reshape National HTA Across Europe, Dr. Oriol Solà-Morales?
- How Can HEOR Teams Build Trust in AI-Generated Models, Haidong Feng?
- Can US GLOBE and GUARD Models Really Lower Drug Prices, Brittany La Couture?
- What Will It Take to Keep Biotech Growing in Europe, Rainer Westermann?
- How Do You Build a High-Performing Team in Pharma, Dr. Maurice Kléber?
- Prof. Dr. Wagschal - What can we expect from the upcoming elections in Germany?
- Remo Christen – Early paid access in Switzerland – Switzerland, wonderland??
- Prof. Dr. David Matusiewicz & Dr. Anne Sophie Geier - 1 year DIGAs. Is the "fast track process" for digital health applications successful?
- Bibiane Schulte-Bosse - How to fight well in AMNOG negotiations.
- Prof. Peter Zweifel & Door Vonk - Digital innovation - from theory into practice!
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.